Phase 2 Depressive Disorder, Treatment-Resistant Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Major Depressive Disorder (MDD)Depressive Disorder, Treatment-Resistant
ACADIA Pharmaceuticals Inc.153 enrolled13 locationsNCT07284667
Recruiting
Phase 2
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908
Recruiting
Phase 2
Intravenous Ketamine for Treatment-Resistant Depression
Treatment Resistant Depression (TRD)Depressive Disorder, Treatment-Resistant
Mayo Clinic30 enrolled1 locationNCT06668571
Recruiting
Phase 2
OSU6162 as add-on in SSRI/SNRI-resistant Depression
DepressionDepressive DisorderDepressive Disorder, Treatment-Resistant+3 more
Göteborg University180 enrolled4 locationsNCT05641623